Cargando…
Pharmacokinetic properties and bioequivalence of gefitinib 250 mg in healthy Korean male subjects
Gefitinib is an anti-cancer drug used to treat non-small cell lung cancer. The objective of this study was to compare the pharmacokinetics and evaluate the bioequivalence of 2 orally administered gefitinib 250 mg tablets in healthy Korean subjects. A randomized, open-label, single-dose, crossover bi...
Autores principales: | Moon, Seol Ju, Kim, Yunjeong, Jeon, Ji-Young, Park, Shin-Jung, Kwak, Yong-Geun, Kim, Min-Gul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Clinical Pharmacology and Therapeutics
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492391/ https://www.ncbi.nlm.nih.gov/pubmed/34621709 http://dx.doi.org/10.12793/tcp.2021.29.e17 |
Ejemplares similares
-
Pharmacokinetic comparison of two bazedoxifene acetate 20 mg tablet formulations in healthy Korean male volunteers
por: Yeun, Ji-Sun, et al.
Publicado: (2020) -
Orally Formulated Artemisinin in Healthy Fasting Vietnamese Male Subjects: A Randomized, Four-Sequence, Open-Label, Pharmacokinetic Crossover Study
por: Hien, Tran Tinh, et al.
Publicado: (2011) -
Association of Variability and Pharmacogenomics With Bioequivalence of Gefitinib in Healthy Male Subjects
por: Zhang, Hong, et al.
Publicado: (2018) -
Pharmacokinetic interactions between telmisartan/amlodipine and rosuvastatin after multiple oral administrations in healthy Korean male subjects
por: Moon, Seol Ju, et al.
Publicado: (2019) -
Evaluation of Bioequivalency and Pharmacokinetic Parameters for Two Formulations of Glimepiride 1-mg in Chinese Subjects
por: Ju, Gehang, et al.
Publicado: (2020)